{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:53:41Z","timestamp":1786989221463,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007590","name":"Colorado Department of Public Health and Environment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007236","name":"Office of Justice Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007236","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000074","name":"U.S. Department of Justice","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005196","name":"Bureau of Justice Assistance","doi-asserted-by":"publisher","award":["2018-PM-BX-K125"],"award-info":[{"award-number":["2018-PM-BX-K125"]}],"id":[{"id":"10.13039\/100005196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpmfocus.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJPM Focus"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.focus.2025.100460","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T11:58:25Z","timestamp":1761652705000},"page":"100460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Examining Statewide Opioid Prescribing Limits and Prescription Drug Monitoring Program Mandates: Provider Compliance and Patient Outcomes"],"prefix":"10.1016","volume":"5","author":[{"given":"Jason","family":"Hoppe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5555-5714","authenticated-orcid":false,"given":"Heather","family":"Tolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2836-0107","authenticated-orcid":false,"given":"Katherine J.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7476-7541","authenticated-orcid":false,"given":"Katherine","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6289-9689","authenticated-orcid":false,"given":"Zachary","family":"Giano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6301-116X","authenticated-orcid":false,"given":"Barbara","family":"Gabella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.focus.2025.100460_bib0002","series-title":"Understanding the opioid overdose epidemic","year":"2024"},{"issue":"26","key":"10.1016\/j.focus.2025.100460_bib0003","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006\u20132015","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.focus.2025.100460_bib0004","unstructured":"Key Substance Use and Mental Health Indicators in the United States: Results From the 2023 National Survey on Drug Use and Health (HHS Publication No. PEP24-07-021, NSDUH Series H-59) 2024.https:\/\/www.samhsa.gov\/data\/report\/2023-nsduh-annual-national-report Accessed December 12, 2024"},{"key":"10.1016\/j.focus.2025.100460_bib0005","unstructured":"U.S. overdose deaths decrease in 2023, first time since 2018. Center for Disease Control and Prevention.https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2024\/20240515.htm. Updated May 15, 2024. Accessed September 10, 2025."},{"issue":"10","key":"10.1016\/j.focus.2025.100460_bib0006","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/jamia\/ocae160","article-title":"State-level factors associated with implementation of prescription drug monitoring program integration and mandatory use policies, United States, 2009\u20132020","volume":"31","author":"Johnson","year":"2024","journal-title":"J Am Med Inform Assoc"},{"issue":"5","key":"10.1016\/j.focus.2025.100460_bib0007","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archinternmed.2011.1827","article-title":"Long-term analgesic use after low-risk surgery: a retrospective cohort study","volume":"172","author":"Alam","year":"2012","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.focus.2025.100460_bib0008","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.annemergmed.2014.11.015","article-title":"Association of emergency department opioid initiation with recurrent opioid use","volume":"65","author":"Hoppe","year":"2015","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.focus.2025.100460_bib0009","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.drugalcdep.2018.09.022","article-title":"Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: a national systematic legal review","volume":"194","author":"Davis","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.focus.2025.100460_bib0010","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/YCO.0000000000000608","article-title":"Advances in prescription drug monitoring program research: a literature synthesis (June 2018 to December 2019)","volume":"33","author":"Delcher","year":"2020","journal-title":"Curr Opin Psychiatry"},{"issue":"12","key":"10.1016\/j.focus.2025.100460_bib0011","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jpain.2019.04.007","article-title":"Effectiveness of prescription monitoring programs in reducing opioid prescribing, dispensing, and use outcomes: a systematic review","volume":"20","author":"Wilson","year":"2019","journal-title":"J Pain"},{"issue":"9","key":"10.1016\/j.focus.2025.100460_bib0012","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/hec.4020","article-title":"How well do doctors know their patients? Evidence from a mandatory access prescription drug monitoring program","volume":"29","author":"Buchmueller","year":"2020","journal-title":"Health Econ"},{"issue":"2","key":"10.1016\/j.focus.2025.100460_bib0013","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.0234","article-title":"Changes in opioid use after Florida\u2019s restriction law for acute pain prescriptions","volume":"3","author":"Hincapie-Castillo","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.focus.2025.100460_bib0014","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/00952990.2020.1853140","article-title":"Opioid days\u2019 supply limits: an interrupted time-series analysis of opioid prescribing before and following a Massachusetts law","volume":"47","author":"Hackman","year":"2021","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"12","key":"10.1016\/j.focus.2025.100460_bib0015","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1001\/jamainternmed.2021.4281","article-title":"Association of state opioid prescription duration limits with changes in opioid prescribing for Medicare beneficiaries","volume":"181","author":"Cramer","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.focus.2025.100460_bib0016","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/10826084.2018.1491052","article-title":"Perceived unintended consequences of prescription drug monitoring programs","volume":"54","author":"Yuanhong Lai","year":"2019","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.focus.2025.100460_bib0017","unstructured":"Colorado General Assembly, Senate bill 18-022, 2018, Colorado General Assembly; Denver, CO https:\/\/leg.colorado.gov\/sites\/default\/files\/documents\/2018A\/bills\/2018a_022_enr.pdf, Published Accessed April 3, 2025."},{"key":"10.1016\/j.focus.2025.100460_bib0018","unstructured":"New law affects Colorado prescribers, limits opioid prescriptions. Colorado Department of Regulatory Agencies Division of Professions and Occupations.https:\/\/content.govdelivery.com\/accounts\/CODORA\/bulletins\/1f1efcc. Updated May 23, 2018. Accessed May 8, 2025."},{"key":"10.1016\/j.focus.2025.100460_bib0019","unstructured":"Guidelines for the safe prescribing and dispensing of opioids. Colorado Department of Regulatory Agencies Division of Professions and Occupations.https:\/\/drive.google.com\/file\/d\/19xrPqsCbaHHA9nTD1Fl3NeCn5kwK60zR\/view. Updated March 14, 2019. Accessed May 8, 2025."},{"key":"10.1016\/j.focus.2025.100460_bib0020","unstructured":"KM. Campbell, Rule your data with the link King\u00a9(a SAS\/AF\u00ae application for record linkage and unduplication), SUGI. 2005;30:1\u20139. https:\/\/support.sas.com\/resources\/papers\/proceedings\/proceedings\/sugi30\/020-30.pdf. Accessed May 8, 2025."},{"issue":"1","key":"10.1016\/j.focus.2025.100460_bib0021","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1460458208088855","article-title":"Record linkage software in the public domain: a comparison of Link Plus, The Link King, and a \u2018basic\u2019 deterministic algorithm","volume":"14","author":"Campbell","year":"2008","journal-title":"Health Informatics J"},{"issue":"11","key":"10.1016\/j.focus.2025.100460_bib0022","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/acem.14071","article-title":"Association of emergency department opioid administration with ongoing opioid use: a retrospective cohort study of patients with back pain","volume":"27","author":"Heard","year":"2020","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.focus.2025.100460_bib0023","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.drugalcdep.2018.03.036","article-title":"Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing","volume":"188","author":"Winstanley","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.focus.2025.100460_bib0024","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/pds.1878","article-title":"Usefulness of prescription monitoring programs for surveillance\u2013analysis of Schedule II opioid prescription data in Massachusetts, 1996\u20132006","volume":"19","author":"Katz","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"10.1016\/j.focus.2025.100460_bib0025","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s11606-021-07119-3","article-title":"Rapid discontinuation of chronic, high-dose opioid treatment for pain: prevalence and associated factors","volume":"37","author":"Stein","year":"2022","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1016\/j.focus.2025.100460_bib0026","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/1475-6773.13548","article-title":"The importance of data source in prescription drug monitoring program research","volume":"56","author":"Horwitz","year":"2021","journal-title":"Health Serv Res"},{"issue":"10","key":"10.1016\/j.focus.2025.100460_bib0027","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/add.13860","article-title":"Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 U.S. states","volume":"112","author":"Moyo","year":"2017","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.focus.2025.100460_bib0028","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1377\/hlthaff.2014.1085","article-title":"Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access","volume":"34","author":"Rutkow","year":"2015","journal-title":"Health Aff (Millwood)"},{"issue":"6","key":"10.1016\/j.focus.2025.100460_bib0029","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/pme.12700","article-title":"How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?","volume":"16","author":"Smith","year":"2015","journal-title":"Pain Med"},{"issue":"6","key":"10.1016\/j.focus.2025.100460_bib0030","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/pm\/pnw251","article-title":"Clinicians\u2019 use of prescription drug monitoring programs in clinical practice and decision-making","volume":"18","author":"Leichtling","year":"2017","journal-title":"Pain Med"},{"issue":"suppl 1","key":"10.1016\/j.focus.2025.100460_bib0031","first-page":"S16","article-title":"Emergency physician interpretation of prescription drug monitoring program profiles","volume":"22","author":"Hoppe","year":"2015","journal-title":"Acad Emerg Med"},{"issue":"1","key":"10.1016\/j.focus.2025.100460_bib0032","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.annemergmed.2009.12.011","article-title":"A statewide prescription monitoring program affects emergency department prescribing behaviors","volume":"56","author":"Baehren","year":"2010","journal-title":"Ann Emerg Med"},{"issue":"4","key":"10.1016\/j.focus.2025.100460_bib0033","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.annemergmed.2013.05.025","article-title":"Clinician impression versus prescription drug monitoring program criteria in the assessment of drug-seeking behavior in the emergency department","volume":"62","author":"Weiner","year":"2013","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.focus.2025.100460_bib0034","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1377\/hlthaff.2020.01316","article-title":"Provider compliance with Kentucky\u2019s prescription drug monitoring program\u2019s mandate to query patient opioid history","volume":"40","author":"Carey","year":"2021","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.focus.2025.100460_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2019.02.010","article-title":"Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing","volume":"199","author":"Strickler","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.focus.2025.100460_bib0036","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/1073110518782948","article-title":"The impact of prescription drug monitoring programs on U.S. opioid prescriptions","volume":"46","author":"Ayres","year":"2018","journal-title":"J Law Med Ethics"},{"key":"10.1016\/j.focus.2025.100460_bib0037","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.urology.2020.02.002","article-title":"Decrease in urologic discharge opioid prescribing after mandatory query of statewide prescription drug monitoring program","volume":"139","author":"Myrga","year":"2020","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.focus.2025.100460_bib0038","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/pds.4404","article-title":"Impact of Florida\u2019s prescription drug monitoring program and pill mill law on high-risk patients: a comparative interrupted time series analysis","volume":"27","author":"Chang","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.focus.2025.100460_bib0039","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.addbeh.2017.08.032","article-title":"Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain","volume":"76","author":"Lin","year":"2018","journal-title":"Addict Behav"},{"issue":"9","key":"10.1016\/j.focus.2025.100460_bib0040","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1377\/hlthaff.2019.00103","article-title":"Prescription drug monitoring program mandates: impact on opioid prescribing and related hospital use","volume":"38","author":"Wen","year":"2019","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"10.1016\/j.focus.2025.100460_bib0041","doi-asserted-by":"crossref","first-page":"e759","DOI":"10.1097\/SLA.0000000000005283","article-title":"Association between state limits on opioid prescribing and the incidence of persistent postoperative opioid use among surgical patients","volume":"277","author":"Sun","year":"2023","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.focus.2025.100460_bib0042","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/1475-6773.14023","article-title":"Effects of state opioid prescribing cap laws on opioid prescribing after surgery","volume":"57","author":"Schmid","year":"2022","journal-title":"Health Serv Res"},{"issue":"5","key":"10.1016\/j.focus.2025.100460_bib0043","doi-asserted-by":"crossref","first-page":"617","DOI":"10.7326\/M21-4363","article-title":"Effects of state opioid prescribing laws on use of opioid and other pain treatments among commercially insured U.S. adults","volume":"175","author":"McGinty","year":"2022","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.focus.2025.100460_bib0044","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.amepre.2023.08.015","article-title":"Impact of statewide statute limiting days\u2019 supply to opioid-naive patients","volume":"66","author":"Sullivan","year":"2024","journal-title":"Am J Prev Med"},{"issue":"1","key":"10.1016\/j.focus.2025.100460_bib0045","doi-asserted-by":"crossref","DOI":"10.1186\/s13011-021-00349-y","article-title":"Assessing the impact of a restrictive opioid prescribing law in West Virginia","volume":"16","author":"Sedney","year":"2021","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"10.1016\/j.focus.2025.100460_bib0046","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11606-016-3810-3","article-title":"Association between initial opioid prescribing patterns and subsequent long-term use among opioid-na\u00efve patients: a statewide retrospective cohort study","volume":"32","author":"Deyo","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"5","key":"10.1016\/j.focus.2025.100460_bib0047","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s11606-015-3539-4","article-title":"Opioid prescribing at hospital discharge contributes to chronic opioid use","volume":"31","author":"Calcaterra","year":"2016","journal-title":"J Gen Intern Med"},{"issue":"10","key":"10.1016\/j.focus.2025.100460_bib0048","doi-asserted-by":"crossref","first-page":"265","DOI":"10.15585\/mmwr.mm6610a1","article-title":"Characteristics of initial prescription episodes and likelihood of long-term opioid use\u2014United States, 2006\u20132015","volume":"66","author":"Shah","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.focus.2025.100460_bib0049","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/ajad.13154","article-title":"Prescription drug monitoring program: access in the first year","volume":"30","author":"Crawford","year":"2021","journal-title":"Am J Addict"},{"issue":"10","key":"10.1016\/j.focus.2025.100460_bib0050","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/add.13741","article-title":"Do more robust prescription drug monitoring programs reduce prescription opioid overdose?","volume":"112","author":"Pardo","year":"2017","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.focus.2025.100460_bib0051","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/08897077.2019.1695707","article-title":"Do prescription drug monitoring programs encourage prescription - or illicit - opioid abuse?","volume":"42","author":"Meadowcroft","year":"2021","journal-title":"Subst Abus"},{"issue":"5","key":"10.1016\/j.focus.2025.100460_bib0052","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/1475-6773.13197","article-title":"Prescription drug monitoring programs: assessing the association between \u201cbest practices\u201d and opioid use in Medicare","volume":"54","author":"Moyo","year":"2019","journal-title":"Health Serv Res"},{"issue":"1\u20132","key":"10.1016\/j.focus.2025.100460_bib0053","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pain.2004.05.020","article-title":"Chronic pain and frequent use of health care","volume":"111","author":"Blyth","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.focus.2025.100460_bib0054","unstructured":"State PDMP profiles and contacts. Prescription Drug Monitoring Program Training and Technical Assistance Center. https:\/\/www.pdmpassist.org\/. Updated 2025. Accessed May 8, 2025."}],"container-title":["AJPM Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2773065425001488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2773065425001488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:44:42Z","timestamp":1776771882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2773065425001488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2773065425001488"],"URL":"https:\/\/doi.org\/10.1016\/j.focus.2025.100460","relation":{},"ISSN":["2773-0654"],"issn-type":[{"value":"2773-0654","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining Statewide Opioid Prescribing Limits and Prescription Drug Monitoring Program Mandates: Provider Compliance and Patient Outcomes","name":"articletitle","label":"Article Title"},{"value":"AJPM Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.focus.2025.100460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100460"}}